CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2579533&ei=oIaaUpjiMKTisQeQfQ&usg=AFQjCNHt7XSipQQ1ZsXlT804HjeUykW7qw
Celgene Corporation Raises FY 2012 Guidance
Thursday, 26 Jul 2012 07:30am EDT
Celgene Corporation announced that it is raising fiscal 2012 earnings guidance and reaffirmed revenue guidance. The Company expects non-GAAP diluted EPS to increase approximately 27% year-over-year to a range of $4.80 to $4.85, up from a previous range of $4.70 to $4.80, GAAP diluted EPS to increase approximately 31% year-over-year to a range of $3.69 to $3.80, up from the previous range of $3.52 to $3.67 and Non-GAAP total revenue to increase approximately 15% year-over-year to a range of $5,400 to $5,600 million.Â 
